(RTTNews) - ICON Plc (ICLR), healthcare intelligence and ... ICLR was down by 9.12 percent at $198.10 in the pre-market trade on the Nasdaq. The views and opinions expressed herein are the views ...
CHICAGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Rush Street Interactive, Inc. (NYSE: RSI) (“RSI”), a premier online casino and sports betting operator, is thrilled to announce a new exclusive ...
Royal Bank of Canada reissued their outperform rating on shares of ICON Public (NASDAQ:ICLR – Free Report) in a research report report published on Wednesday morning,Benzinga reports.
Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Icon ( (ICLR ...
Fintel reports that on January 7, 2025, RBC Capital initiated coverage of ICON Public Limited (NasdaqGS:ICLR) with a Outperform recommendation. As of December 23, 2024, the average one-year price ...
Energy Corp. (NASDAQ:ICON), a global dry bulk shipping service provider, has announced the pricing of its public offering of over 9 million units at $1.31 each. According to InvestingPro data, this ...
ICON ( NASDAQ: ICLR) stock fell 8% early Tuesday after it issued financial guidance for 2025. The clinical research ...
Shares of NASDAQ:ICLR opened at $199.47 on Tuesday. ICON Public has a one year low of $183.38 and a one year high of $347.72. The company has a debt-to-equity ratio of 0.35, a current ratio of 1. ...
Completely Redesigned From Bow to Stern, The 23- and 25-Foot XStar Models Combine Legendary Performance With Cutting-Edge Innovation and Bold New Styling Upgrades Include New MAAX Audio, Z100 ...
Icon Energy (ICON) announced the pricing of its public offering of 9,160,305 units at a public offering price of $1.31 per unit. Each unit ...
VALENCIA, Calif., Dec. 31, 2024 /PRNewswire/ -- Cunard is setting the tempo for music collaborations in 2025 with globally renowned jazz artists Jools Holland OBE and Jamie Cullum* headlining ...
ICON (NASDAQ:ICLR) stock fell 8% early Tuesday after it issued financial guidance for 2025. The clinical research organization said that it expects to report 2025 revenue of $8.05B to $8.650B ...